CD163 and neoplasm: Furthermore, hrHPV+ patients with aggressive tumors, may benefit from such combinatorial therapy, as we showed a probable association between high infiltration rates of CD68+ and CD163+ cells in the peritumoral tumor (PT Tumor) and lymph node metastasis.